Wanbury’s Patalganga manufacturing site has successfully received Good Manufacturing Practices (GMP) certificate from the office of Brazil Health Regulatory Agency (ANVISA). On May 12, the company had received certificate from ANVISA for its Tanuku Site, Andhra Pradesh.
Brazil Health Regulatory Agency reviewed inspection report of USFDA and other documents of Wanbury Patalganga site. As a result, ANVISA has granted the Good Manufacturing Practices (GMP) certificate for the facility. With this certificate, now both the API manufacturing sites of Wanbury are continued to be compliant per ANVISA' s rules & regulations.
Wanbury, one of India’s fastest growing pharmaceutical companies amongst the ‘Top 50 Companies’ in India (as per ORG-IMS), has a strong presence in API global market and domestic branded Formulation.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: